Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Washed Microbiota Transplantation for Allergic Rhinitis
NCT06372184Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Jun 2024
- Primary completion
- Jun 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in allergic rhinitis (AR) comparing Washed microbiota transplantation with Placebo (2 arms). Primary endpoint: Reflective Total Nasal Symptom Score at 12 weeks. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
washed microbiota transplantation
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT06372184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06372184.